In an era defined by rapid technological advancement, Sheba stands at the nexus of innovation and patient care. In a recent Sheba study published in the International Journal of Emergency Medicine, an AI algorithm developed by Aidoc for early detection of intracerebral hemorrhage (ICH) showed significant promise for patients across the globe.
Founded at Sheba, Aidoc is a leader in AI-driven diagnostics that is dedicated to revolutionizing the early detection of life-threatening conditions. Its advanced AI tools are already used in hospitals across the globe.
The new study, which was headed by Dr. David Orion, Director of Sheba’s Acute Stroke & Neuroendovascular Department, showed that use of Aidoc’s AI ICH detection system led to a dramatic 30% decrease in mortality rates. Beyond its lifesaving effects, patients diagnosed with the system also benefitted from a notable uplift in their post-treatment quality of life.
While these findings are a source of immense pride, their implications resonate on a global level. Every day, Sheba welcomes patients from various corners of the world, each with unique stories, hopes, and worries. With Aidoc’s AI system, we’re poised to offer patients not only the promise of a precise diagnosis, but a swifter, safer treatment journey while navigating a foreign healthcare system.
As we look to the future, our vision remains unclouded – a world where top-tier diagnostic and treatment solutions are accessible to all, regardless of geographical boundaries.